aluminum maltolate has been researched along with deferoxamine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boyd, JC; Herman, MM; Huang, Y; Nicholson, JR; Reyes, MR; Savory, J; Wills, MR | 1 |
| Farber, JL; Savory, J; Serroni, A; Snyder, JW | 1 |
| Herman, MM; Huang, Y; Savory, J; Wills, MR | 1 |
3 other study(ies) available for aluminum maltolate and deferoxamine
| Article | Year |
|---|---|
Quantitative evaluation of Al maltolate-induced neurodegeneration with subsequent Al removal by desferrioxamine treatment.
Topics: Aluminum; Animals; Chelating Agents; Deferoxamine; Male; Nerve Degeneration; Organometallic Compounds; Pyrones; Rabbits | 1995 |
The absence of extracellular calcium potentiates the killing of cultured hepatocytes by aluminum maltolate.
Topics: Aluminum; Animals; Calcium; Cell Death; Cell Membrane Permeability; Cyclic AMP; Deferoxamine; Dose-Response Relationship, Drug; Liver; Male; Mitochondria; Organometallic Compounds; Oxidative Stress; Protein Kinases; Pyrones; Rats; Rats, Sprague-Dawley; Terpenes; Tetradecanoylphorbol Acetate; Thapsigargin; Thionucleotides; Time Factors | 1995 |
Reversal by desferrioxamine of tau protein aggregates following two days of treatment in aluminum-induced neurofibrillary degeneration in rabbit: implications for clinical trials in Alzheimer's disease.
Topics: Aluminum; Alzheimer Disease; Animals; Brain; Deferoxamine; Male; Neurofibrillary Tangles; Organometallic Compounds; Pyrones; Rabbits; Spinal Cord; tau Proteins | 1998 |